Home » Topics » Regulatory

Regulatory
RSS

FDA approves Xalkori for ROS1-positive metastatic NSCLC

March 14, 2016

FDA approves Odefsey single-tablet regimen for HIV-1 infection

March 2, 2016

FDA approves Gazyva for use in follicular lymphoma

Feb. 29, 2016

Takeda's combination packs for H. pylori eradication approved in Japan

Feb. 26, 2016

FDA approves Ibrance for new metastatic breast cancer indication

Feb. 24, 2016

FDA approves Halaven in new indication

Jan. 29, 2016

FDA approves Merck & Co.'s Zepatier for HCV infection

Jan. 29, 2016

Expanded FDA approvals for Opdivo + Yervoy and single-agent Opdivo in melanoma

Jan. 25, 2016

UCB's Briviact approved in E.U. as adjunctive treatment for partial-onset seizures

Jan. 22, 2016

FDA approves Neulasta to treat radiation sickness

Jan. 21, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...